Description
Ophthalmology is entering one of the most remarkable phases in recent history of this industry; new technologies and treatment modalities for both visual acuity and major eye diseases may dramatically change the composition and competitive dynamics of this market. As RK and LASIK changed the market a few years ago, even newer competitive technologies are just now emerging. From the advent of photodynamic therapy and new drug delivery techniques to revolutionary surgical approaches to refractive vision correction, ophthalmology is poised to see a plethora of new treatment options.
This major new report covers the US and international markets for refractive vision correction, including
- Myopia,
- Hyperopia,
- Presbyopia, and
- Astigmatism
And US and international markets for the treatment of major eye diseases, including
- cataract,
- glaucoma,
- age-related macular degeneration (AMD), and
- other vitreoretinal conditions such as diabetic retinopathy, diabetic macular edema, and detached retina.
In addition to comprehensive analysis of the market forces and competitive dynamics, the study provides extensively detailed market size, market growth, procedure volume and market share data for each subsegment through 2008, including details on:
- Laser systems for vision correction,
- Lens implants for vision correction,
- Diagnostic and visual acuity services,
- Cararact surgery,
- Intraocular lenses (IOLs) for cataracts,
- Ophthalmic pharmaceuticals for glaucoma,
- Diagnostics for glaucoma, and
- Treatments and diagnostics for AMD and other vitreoretinal conditions, including photodynamic therapy (PDT) and anti-vascular endothelial growth factor (anti-VEGF)
Complete market forecasts are also provided by disease or vision condition (as noted above) and by provider segment, including
- Ophthalmologists,
- Optometrists,
- Vision Care Centers,
- Eye Clinics, and
- Others
Profiles of nearly 50 major players in the market complete the all-inclusive market assessment.
Table of Contents
CHAPTER ONE: Executive Summary
- Overview
- Objectives, Scope, and Methodology
- Summary Of Findings
- Overview of Current Market Dynamics
- Refractive Vision Correction
- Observations and Recommendations
- Market Analysis and Forecasts
- Major Eye Diseases
- Observations and Recommendations
- Market Analysis and Forecast
- Recent Market Events
- Refractive Vision Correction
- Technology
- Business & Markets
- Major Eye Diseases
- Technology
- Business & Markets
Chapter Two: The Dynamics of Change
- Business Issues
- No Longer Business as Usual
- Resistance to Change
- The New Technological Revolution
- Competition Old vs New
- Rushing to Development vs the Risk of Obsolescense
- Refractive Vision Correction [RVC]
- Major Eye Diseases
- Regulation
- Government’s Role as Overseer
- Government Mandate: Safety & Effectiveness
- Developed & Underdeveloped Countries
- Off-Label Use
- Ophthalmologists vs Optometrists
- Business Challenges in a Regulated Environment
- Intellectual Property, Asset Ownership
- International Trade [Export / Import]
- Governance in a Publicly-Owned Company
Chapter Three: Restoration of Impaired Vision
- Treatment of Leading Vision Disorders
- Conventional Eye Glasses and Contact Lens
- Conventional Eye Glasses
- Traditional Contact Lenses
- Alternative Surgical Modalities
- LASIK / Laser Surgery Intervention
- RF Conductive Keratoplasty [RFK]
- Other Innovative Treatment Options
- Correctable Vision Implants—Spacers/Inserts
- Temporary Correctable Vision Lenses
- Lens Implants—Phakic & Implantable Lens Implants [ICL]
- Challenges & Threats in the Global Marketplace
Chapter Four: Vision Impacted by Disease
- Overview
- Cataracts
- Glaucoma
- Macular Degeneration
- Vitreoretinal Disorders
- Diabetic Retinopathy [DR]
- Diabetic Macular Edema [DME]
- Retinal Detachment [RD]
Chapter Five: Refractive Vision Correction: Products and Technologies
- Competing Treatment Technologies and Competitive Maneuvers
- Competitive Products, Technology, Applications & Market Status
Chapter Six: Major Eye Diseases
- Overview
- Summary of Competing Technologies
- Cataract
- Glaucoma
- Age-Related Macular Degeneration
- Vitreoretinal Conditions
Chapter Seven: Market Dynamics
- Description of the Market
- Eye Care Challenges
- The Aging Process and Complications of Chronic Conditions
- Technology Overcomes Obsolete Methodologies
- Older Treatment Modalities
- Advanced Treatment Modalities
- The Competitive Arena
- Pressures Influencing Structural Changes
- Market Influences
- The Total Market
- Refractive Vision Correction
- Eye Diseases
Chapter Eight: Growth Forecasts
Bases of Market Forecast Market Forecasts—Growth Rates
Chapter Nine: Refractive Vision Correction
- Market Analysis & Forecast
- Background
- Eye Glasses & Contact Lenses
- Prevention & Wellness
- Laser Surgery & Other Corrective Alternatives
- Competitive Market & Forecast
- Market Size and Market Share
- Market Size, Share, and Procedure Forecasts
- Major Markets Forecast—Service Providers
Chapter Ten: Major Eye Diseases: Market
- Analysis & Forecast
- Market Challenges
- Market Size and Share
- Market Size, Share And Procedure Forecasts
- Overview
- Cataract Surgery and IOL [Intraocular] Lens
- Glaucoma Treatment and Management
- VitreoRetinal—Conventional & Advanced Treatments
- Major Markets Forecast—Service Providers
Chapter Eleven: Company Profiles, Abstracts, and Briefs
- Advanced Medical Optics, Inc
- Business Overview
- Products -Technology—Intellectual Assets
- Analysis of Markets, Comments & Competitive Challenges
- Alcon Laboratories, Inc
- Business Overview
- Products -Technology- Intellectual Property
- Analysis of Markets, Comments & Competitive Challenges
- Alimera Sciences, Inc. [Asi]
- Allergan, Inc
- Business Overview
- Products / Technology / Intellectual Property
- Analysis of Markets; Comments & Competitive Challenges
- The Amacore Group, Inc [Formerly Eyecare International, Inc.]
- Anika Therapeutics, Inc
- Bausch & Lomb, Inc
- Business Overview
- Products / Technology / Intellectual Property
- Analysis of Markets, Comments & Competitive Challenges
- The Cooper Companies, Inc. [Cooper Vision, Inc.]
- Business Overview
- Maarket Analysis – Comments – Challenges
- Coronado Industries, Inc Sub: Ophthalmic International [OI]
- Business Overview
- Market Analysis – Comments – Challenges
- Eyeonics, Inc
- Business Overview
- Market Analysis – Comments – Challenges
- Eyetech Pharmaceuticals, Inc
- Business Overview
- Product-Technology-Intellectual Property
- Analysis of Market- Comments – Challenges
- Genaera Corporation
- Business Overview
- Market Analysis – Comments – Challenges
- Genetech, Inc
- Business Overview
- Comments & Analysis
- Heidelberg Engineering, Inc
- Business Overview
- Market Analysis – Comments – Challenges
- Insight Vision, Inc
- Business Overview
- Market Analysis – Comments – Challenges
- Inspire Pharmaceuticals, Inc
- Company Overview
- Market Analysis – Comments – Challenges
- Intralase Corporation
- Business Overview
- Products—Technology—Intellectual Property
- Analysis – Comments – Competitive Challenges
- Iridex Corportion
- Business Overview
- Market Analysis – Comments – Challenges
- Keravision, Inc
- Lasersight Incorporated
- LCA Vision Inc
- Light Sciences Corporation [LSC] Sub: Visient Therapeutics [VT]
- Lumenis, Inc
- Business Overview
- Products – Technology – Intellectual Property
- Analysis – Comments – Challenges
- Miravant Medical Technologies
- Business Overview
- Market Analysis – Comments – Challenges
- Nidek Technologies
- Business Overview
- Products – Technology – Intellectual Property
- Analysis – Comments – Challenges
- Novadaq Technologies, Inc
- Novamed, Inc
- Novartis Ophthalmics
- Business Overview
- Market Analysis – Comments – Challenges
- Novavision, Inc
- Occulogix, Inc.
- Ophtec U.S.A
- Business Overview
- Market Analysis – Comments – Challenges
- Paradigm Medical Industries, Inc
- Business Overview
- Market Analysis – Comments – Challenges
- QLT Inc
- Business Overview
- Comments / Analysis
- Refocus Group Inc [RFI]
- Business Overview
- Market Analysis – Comments – Challenges
- Refractec, Inc
- Business Overview
- Market Analysis – Comments – Challenges
- Regeneron Pharmaceuticals, Inc
- Solx, Inc
- Company Overview
- Market Analysis – Comments – Challenges
- STAAR Surgical Company
- Business Overview:
- Products / Technology / Intellectual Property:
- Analysis, Comments & Competitive Challenges
- Surgilight, Inc
- Business Overview
- Market Analysis – Comments – Challenges
- Talia Technology U.S.A Inc
- Business Overview
- Comments & Analysis
- TLC Vision Corporation
- Unilens Corporation
- Vision Care Ophthalmic Technologies Inc
- Business Overview
- Comments & Analysis
- VISX, Inc
- Business Overview
- Products, Technology and Intellectual Property
- Analysis of Markets, Comments & Competitive Challenges
Appendix A: Registered Trademarks & Trade Names in Refractive Vision Correction
Appendix B: Registered Trademarks & Trade Names in Major Eye Disease
Appendix C: Glossary and Abbreviations
Appendix D: Professional/Scientific Sources
Appendix E: News/Research Sources
Appendix F: U.S. Regulatory Authorities and Statutes
Appendix G: International Regulatory Authorities and Statutes
List of Exhibits
CHAPTER ONE: Executive Summary
- Table 1-1: RVC Surgery Market Summary Revenue Distribution by Condition Type and Geography (Myopia, Hyperopia, Presbyopia, and Astigmatism; U.S. vs Non-U.S.) Total Revenue by Geography (U.S. vs Non-U.S.) 2004-2008
- Table 1-2: Market Summary for Laser Systems, Services; Lens Implants Revenue Distribution by Type and Geography (Laser Systems, Services/Fees; Lens Implants; U.S. vs Non-U.S.) Total Revenue by Geography (U.S. vs Non-U.S.) 2004-2008
- Table 1-3: Market Summary for Major Eye Diseases Revenue Distribution by Disease Type and Geography (Cataracts, Glaucoma, and Vitreoretinal Conditions; U.S. vs Non-U.S.) Total Revenue by Geography (U.S. vs Non-U.S.) 2004-2008
- Table 1-4: Market Summary for Major Eye Disease Revenue Distribution by Major Market Segments and Geography (Ophthalmologist, Vision Care Centers, Optometrists; U.S. vs. Non-U.S.) Total Revenue by Geography (U.S. vs. Non-U.S.) 2004-2008
Chapter Three: Restoration of Impaired Vision
- Exhibit 3-1: Primary Visual Aquity Conditions and Refractive Vision Correction Treatment Options
Chapter Four: Vision Impacted by Disease
- Exhibit 4-1: Diagnostics & Treatment Modalities for the Management of Eye Diseases
Chapter Five: Refractive Vision Correction: Products and Technologies
- Exhibit 5-1: Refractive vision correction Competitive Products, Technology, Application, Market Status
Chapter Six: Major Eye Diseases
- Exhibit 6-1: Major Eye Diseases Competitive Products, Technology, Application, Market Status
- Exhibit 6-2: Old Technology vs New Technology in the Management of Major Eye Disease
Chapter Eight: Growth Forecasts
- Exhibit 8-1: Growth Rates for Ophthalmology Segments, 2004-2005, 2006-2007, 2008 [RVC Products by Type, RVC Procedures by Type, Eye Disease Treatments/Diagnostics by Disease and Type, and Service Segments by Type]
- Exhibit 8-2: Growth Rates for Ophthalmology Companies, 2004-2005, 2006-2007, 2008 [44 Companies]
Chapter Nine: Refractive Vision Correction Market Analysis & Forecast
- Exhibit 9-1A: Refractive Vision Correction Market: Supplier Revenues and Market Share by Geography (U.S. vs Global) and Type (Laser Systems and Services) 2004
- Exhibit 9-1B: Refractive Vision Correction Market: Revenues and Market Share by Geography (U.S. vs Non-U.S.) and Type (Laser Systems [LASIK Flap Devices, Other RVC], Lens Implant, Services/Fees) 2004
- Exhibit 9-1C: Refractive Vision Correction Market: Revenues and Market Share by Geography (U.S. vs Non-U.S.) and Condition Treated (Myopia, Hyperopia, Presbyopia, Astigmatism) 2004
- Exhibit 9-2A: Refractive Vision Correction Market Forecast Market Size (U.S. vs Non-U.S.) by Type (Products and Services vs Lens Implants) and Supplier Revenues and Market Share in the United States 2005-2008
- Exhibit 9-2B: Refractive Vision Correction Market Forecast: Revenues and Market Share by Geography (U.S. vs Non-U.S.) and Type (Laser Systems [LASIK Flap Devices, Other RVC], Lens Implant, Services/Fees) 2005-2008
- Exhibit 9-2C: Refractive Vision Correction Market Forecast: Revenues and Market Share by Geography (U.S. vs Non-U.S.) and Condition Treated (Myopia, Hyperopia, Presbyopia, Astigmatism) 2005-2008
- Exhibit 9-2D: Refractive Vision Correction Lens Implants Market Forecast: Supplier Revenues and Market Share by Geography (U.S. vs Non-U.S.) 2005-2008
- Exhibit 9-3A: Refractive Vision Correction Procedure Forecast Market Size (U.S. vs Non-U.S.) by Type (Products and Services vs Lens Implants) and Supplier Revenues and Market Share in the United States 2004-2008
- Exhibit 9-3B: Refractive Vision Correction Lens Implants Procedure Forecast: Number of Procedures by Supplier by Geography (U.S. vs Non-U.S.) 2004-2008
- Exhibit 9-3C: Refractive Vision Correction Procedures Forecast: Number of Procedures by Geography (U.S. vs Non-U.S.) and Type (Laser Systems [LASIK Flap Devices, Other RVC], Lens Implant, Services/Fees) 2005-2008
- Exhibit 9-3D: Refractive Vision Correction Procedures Forecast: Number of Procedures by Geography (U.S. vs Non-U.S.) and Condition Treated (Myopia, Hyperopia, Presbyopia, Astigmatism) 2005-2008
- Exhibit 9-4A: Refractive Vision Correction Market Forecast: U.S. Service Provider Revenues and Market Share by Type (Laser/LASIK, Services and Fees, Lens Implants) and by Type of Provider (Ophthalmologists, Optometrists, Vision Care Centers, Eye Clinics, and Others) 2005-2008
- Exhibit 9-4B: Refractive Vision Correction Forecast: U.S. Market Share by Service Type (Laser/LASIK, Visual Acuity Exams, Services and Fees, Lens Implants) by Type of Provider (Ophthalmologists, Vision Care Centers, and Others) 2005-2008
Chapter Ten: Major Eye Diseases: Market Analysis & Forecast
- Exhibit 10-1: Major Eye Disease Market: Supplier Revenues and Market Share by Geography (U.S. vs Global) and Condition (Cataract, Glaucoma, Vitreoretinal) 2004
- Exhibit 10-1B: Major Eye Disease Market: Revenues and Market Share by Geography (U.S. vs Global) and Condition (Cataract, Glaucoma, Vitreoretinal) and Treatment Modality (Surgery vs IOL) 2004
- Exhibit 10-2: The Cataract Market: Supplier Revenues and Market Share by Geography (U.S. vs Global) and Treatment Modality (Surgery vs IOL) 2004
- Exhibit 10-3: The Glaucoma Market: Supplier Revenues and Market Share by Geography (U.S. vs Global) and Treatment Modality (Pharmaceuticals vs Other Treatment/Diagnostics) 2004
- Exhibit 10-4: The Vitreoretinal Disorder Market: Supplier Revenues and Market Share by Geography (U.S. vs Global) and Condition (AMD vs Other [Diabetic Retinopathy, Diabetic Macular Edema, Retinal Detatchment]) 2004
- Exhibit 10-5A: Major Eye Disease Market Forecast Supplier Revenues and Market Share Globally (2004) and in the United States (2005-2008)
- Exhibit 10-5B: Major Eye Disease Market Forecast Revenues and Market Share by Disease Type (Cataract, Glaucoma, Retinal Disorders) and Treatment Type Globally (2004) and in the United States (2005-2008)
- Exhibit 10-6: Major Eye Disease Treatment Procedure Forecast: Number of Procedures by Geography (U.S. vs Non-U.S.) and by Condition (Cataract, Glaucoma, AMD, Other Retinal Disorders) 2004-2008
- Exhibit 10-7: Cataract Market Forecast Supplier Revenues and Market Share Globally (2004) and in the United States (2005-2008) and Revenue Forecast (2005-2008) by Product Type (Surgery vs IOL), 2005-2008
- Exhibit 10-8: Glaucoma Market Forecast Supplier Revenues and Market Share Globally (2004) and in the United States (2005-2008) and Revenue Forecast (2005-2008) by Product Type (Pharma vs Other Tx/Dx), 2005-2008
- Exhibit 10-9: Vitreoretinal Market Forecast Supplier Revenues and Market Share Globally (2004) and in the United States (2005-2008) and Revenue Forecast (2005-2008) by Condition Type (AMD vs Other [Diabetic Retinopathy, Diabetic Macular Edema, Retinal Detatchment]), 2005-2008
- Exhibit 10-10: Major Eye Disease Market Forecast: U.S. Service Provider Revenues and Market Share by Type (Pharmaceuticals, Surgery, Dx Exam, IOL) and by Type of Provider (Ophthalmologists, Optometrists, Vision Care Centers, Eye Clinics, and Others) 2005-2008
